KEGG   PATHWAY: ko04520
Entry
ko04520                     Pathway                                
Name
Adherens junction
Description
Cell-cell adherens junctions (AJs), the most common type of intercellular adhesions, are important for maintaining tissue architecture and cell polarity and can limit cell movement and proliferation. At AJs, E-cadherin serves as an essential cell adhesion molecules (CAMs). The cytoplasmic tail binds beta-catenin, which in turn binds alpha-catenin. Alpha-catenin is associated with F-actin bundles directly and indirectly. The integrity of the cadherin-catenin complex is negatively regulated by phosphorylation of beta-catenin by receptor tyrosine kinases (RTKs) and cytoplasmic tyrosine kinases (Fer, Fyn, Yes, and Src), which leads to dissociation of the cadherin-catenin complex. Integrity of this complex is positively regulated by beta -catenin phosphorylation by casein kinase II, and dephosphorylation by protein tyrosine phosphatases. Changes in the phosphorylation state of beta-catenin affect cell-cell adhesion, cell migration and the level of signaling beta-catenin. Wnt signaling acts as a positive regulator of beta-catenin by inhibiting beta-catenin degradation, which stabilizes beta-catenin, and causes its accumulation. Cadherin may acts as a negative regulator of signaling beta-catenin as it binds beta-catenin at the cell surface and thereby sequesters it from the nucleus. Nectins also function as CAMs at AJs, but are more highly concentrated at AJs than E-cadherin. Nectins transduce signals through Cdc42 and Rac, which reorganize the actin cytoskeleton, regulate the formation of AJs, and strengthen cell-cell adhesion.
Class
Cellular Processes; Cellular community - eukaryotes
Pathway map
ko04520  Adherens junction
ko04520

Other DBs
GO: 0005912
Orthology
K02105  CTNNB1; catenin beta 1
K02620  TCF7, TCF-1; transcription factor 7
K03097  CSNK2A; casein kinase II subunit alpha [EC:2.7.11.1]
K03115  CSNK2B; casein kinase II subunit beta
K04237  PARD3; partitioning defective protein 3
K04353  RAP1A; Ras-related protein Rap-1A
K04361  EGFR, ERBB1; epidermal growth factor receptor [EC:2.7.10.1]
K04362  FGFR1, CD331; fibroblast growth factor receptor 1 [EC:2.7.10.1]
K04371  ERK, MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04388  TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K04392  RAC1; Ras-related C3 botulinum toxin substrate 1
K04393  CDC42; cell division control protein 42
K04427  MAP3K7, TAK1; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04468  NLK; nemo like kinase [EC:2.7.11.24]
K04490  TCF7L1; transcription factor 7-like 1
K04491  TCF7L2; transcription factor 7-like 2
K04492  LEF1; lymphoid enhancer-binding factor 1
K04498  EP300, CREBBP, KAT3; E1A/CREB-binding protein [EC:2.3.1.48]
K04501  SMAD4; mothers against decapentaplegic homolog 4
K04513  RHOA; Ras homolog gene family, member A
K04514  ROCK1; Rho-associated protein kinase 1 [EC:2.7.11.39]
K04527  INSR, CD220; insulin receptor [EC:2.7.10.1]
K04674  TGFBR1, ALK5; TGF-beta receptor type-1 [EC:2.7.11.30]
K04678  SMURF; E3 ubiquitin ligase SMURF1/2 [EC:2.3.2.26]
K05083  ERBB2, HER2, CD340; receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1]
K05087  IGF1R, CD221; insulin-like growth factor 1 receptor [EC:2.7.10.1]
K05099  MET, HGFR; proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
K05627  BAIAP2, IRSP53; BAI1-associated protein 2
K05689  CDH1, CDHE, CD324; cadherin 1, type 1, E-cadherin
K05690  CTNND1; catenin (cadherin-associated protein), delta 1
K05691  CTNNA; catenin alpha
K05692  ACTB_G1; actin beta/gamma 1
K05693  PTPRM; receptor-type tyrosine-protein phosphatase mu [EC:3.1.3.48]
K05694  PTPRB, PTPB; receptor-type tyrosine-protein phosphatase beta [EC:3.1.3.48]
K05695  PTPRF, LAR; receptor-type tyrosine-protein phosphatase F [EC:3.1.3.48]
K05696  PTPN1, PTP1B; tyrosine-protein phosphatase non-receptor type 1 [EC:3.1.3.48]
K05697  PTPN6, SHP1; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48]
K05698  PTPRJ, DEP1, CD148; receptor-type tyrosine-protein phosphatase eta [EC:3.1.3.48]
K05699  ACTN1_4; actinin alpha 1/4
K05700  VCL; vinculin
K05701  TJP1, ZO1; tight junction protein 1
K05702  AF6, MLLT4; afadin
K05703  FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K05704  SRC; tyrosine-protein kinase Src [EC:2.7.10.2]
K05705  YES1; tyrosine-protein kinase Yes [EC:2.7.10.2]
K05706  SNAI2, SLUG; snail 2
K05707  SNAI1; snail 1
K05747  WAS; Wiskott-Aldrich syndrome protein
K05748  WASF2; WAS protein family, member 2
K05753  WASF1; WAS protein family, member 1
K06081  NECTIN1, PVRL1, CD111; poliovirus receptor-related protein 1
K06082  FARP2, FRG; FERM, RhoGEF and pleckstrin domain protein 2
K06083  WASF3; WAS protein family, member 3
K06084  LMO7, FBXO20; F-box protein 20
K06085  SSX2IP, ADIP; synovial sarcoma, X breakpoint 2 interacting protein
K06086  SORBS1, SH3D5, PONSIN, CAP; sorbin and SH3 domain containing protein 1
K06531  NECTIN2, PVRL2, CD112; poliovirus receptor-related protein 2
K06533  CDH5, CD144; cadherin 5, type 2, VE-cadherin
K06592  NECTIN3, PVRL3, CD113; poliovirus receptor-related protein 3
K06593  NECTIN4, PVRL4; poliovirus receptor-related 4
K07836  RAP1B; Ras-related protein Rap-1B
K07860  RAC2; Ras-related C3 botulinum toxin substrate 2
K07861  RAC3; Ras-related C3 botulinum toxin substrate 3
K08889  FER, TYK3; tyrosine-protein kinase Fer [EC:2.7.10.2]
K10351  MYL2; myosin regulatory light chain 2
K12753  MYL5; myosin regulatory light chain 5
K12754  MYL7; myosin regulatory light chain 7
K12755  MYL9; myosin regulatory light chain 9
K12756  MYL10; myosin regulatory light chain 10
K12757  MYL12; myosin regulatory light chain 12
K12758  MYLPF; fast skeletal myosin light chain 2
K14394  ACP1; low molecular weight phosphotyrosine protein phosphatase [EC:3.1.3.2 3.1.3.48]
K16848  IQGAP1; Ras GTPase-activating-like protein IQGAP1
K17388  ROCK2; Rho-associated protein kinase 2 [EC:2.7.11.39]
K17705  KRIT1, CCM1; Krev interaction trapped protein 1
K18269  PDCD10, CCM3; programmed cell death protein 10
K20644  ARHGAP29; Rho GTPase-activating protein 29
K23605  SMAD3; mothers against decapentaplegic homolog 3
K23612  WASL; neural Wiskott-Aldrich syndrome protein
K24472  HEG; protein HEG
K26416  CCM2; cerebral cavernous malformations 2
K26417  RASIP1; Ras-interacting protein 1
K26418  RADIL; Ras-associating and dilute domain-containing protein
Reference
  Authors
Nelson WJ, Nusse R.
  Title
Convergence of Wnt, beta-catenin, and cadherin pathways.
  Journal
Science 303:1483-7 (2004)
DOI:10.1126/science.1094291
Reference
  Authors
Potter E, Bergwitz C, Brabant G.
  Title
The cadherin-catenin system: implications for growth and differentiation of endocrine tissues.
  Journal
Endocr Rev 20:207-39 (1999)
DOI:10.1210/edrv.20.2.0362
Reference
  Authors
Beavon IR.
  Title
The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation.
  Journal
Eur J Cancer 36:1607-20 (2000)
DOI:10.1016/S0959-8049(00)00158-1
Reference
  Authors
Reynolds AB, Roczniak-Ferguson A.
  Title
Emerging roles for p120-catenin in cell adhesion and cancer.
  Journal
Oncogene 23:7947-56 (2004)
DOI:10.1038/sj.onc.1208161
Reference
  Authors
Angst BD, Marcozzi C, Magee AI.
  Title
The cadherin superfamily: diversity in form and function.
  Journal
J Cell Sci 114:629-41 (2001)
Reference
  Authors
Lilien J, Balsamo J, Arregui C, Xu G.
  Title
Turn-off, drop-out: functional state switching of cadherins.
  Journal
Dev Dyn 224:18-29 (2002)
DOI:10.1002/dvdy.10087
Reference
  Authors
Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A, Dunach M.
  Title
p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.
  Journal
Mol Cell Biol 23:2287-97 (2003)
DOI:10.1128/MCB.23.7.2287-2297.2003
Reference
  Authors
Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A.
  Title
Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.
  Journal
J Cell Biol 163:847-57 (2003)
DOI:10.1083/jcb.200308162
Reference
  Authors
Ciruna B, Rossant J.
  Title
FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak.
  Journal
Dev Cell 1:37-49 (2001)
DOI:10.1016/S1534-5807(01)00017-X
Reference
  Authors
Peinado H, Quintanilla M, Cano A.
  Title
Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.
  Journal
J Biol Chem 278:21113-23 (2003)
DOI:10.1074/jbc.M211304200
Reference
  Authors
Labbe E, Letamendia A, Attisano L.
  Title
Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
  Journal
Proc Natl Acad Sci U S A 97:8358-63 (2000)
DOI:10.1073/pnas.150152697
Reference
  Authors
Nakanishi H, Takai Y.
  Title
Roles of nectins in cell adhesion, migration and polarization.
  Journal
Biol Chem 385:885-92 (2004)
DOI:10.1515/BC.2004.116
Reference
  Authors
Irie K, Shimizu K, Sakisaka T, Ikeda W, Takai Y.
  Title
Roles and modes of action of nectins in cell-cell adhesion.
  Journal
Semin Cell Dev Biol 15:643-56 (2004)
DOI:10.1016/j.semcdb.2004.09.002
Related
pathway
ko04010  MAPK signaling pathway
ko04060  Cytokine-cytokine receptor interaction
ko04310  Wnt signaling pathway
ko04350  TGF-beta signaling pathway
ko04530  Tight junction
ko04810  Regulation of actin cytoskeleton

DBGET integrated database retrieval system